Evidence map›Paper›PMID 19184677›Full record

ArticlePathology oncology research : POR2009

Zonula occludens-1, occludin, and E-cadherin protein expression in biliary tract cancers.

Zsuzsanna Németh, Attila Marcell Szász, Aron Somorácz, Péter Tátrai, Júlia Németh, Hajnalka Gyorffy, Attila Szíjártó, Péter Kupcsulik, András Kiss, Zsuzsa Schaff

Abstract read
PubMed Publisher
In one paragraph

Article in Pathology oncology research : POR, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Tight Junction Proteins and the Biology of Hepatobiliary Disease.International journal of molecular sciences · 2020
    Review
  7. Review
  8. Article
  9. Low Expression of Occludin in the Melanoma Patient.Iranian journal of pathology · 2019
    Article
  10. Article
  11. Article
  12. Low expression of occludin: a predictor of poor prognosis in esophageal squamous cell carcinoma.International journal of clinical and experimental pathology · 2017
    Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Zsuzsanna Németh2nd Department of Pathology, Semmelweis University, Ulloi út 93, H-1091 Budapest, Hungary.
Attila Marcell Szász
Aron Somorácz
Péter Tátrai
Júlia Németh
Hajnalka Gyorffy
Attila Szíjártó
Péter Kupcsulik
András Kiss
Zsuzsa Schaff
Semmelweis University · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The incidence of cholangiocarcinomas originating from intrahepatic and extrahepatic bile ducts, as well as of gallbladder carcinoma is increasing worldwide. The malignant transformation of biliary epithelia involves profound alterations of proteins in the intercellular junctions, among others zonula occludens-1 (ZO-1), occludin, and E-cadherin. Each plays important role in the maintenance of epithelial cell polarity and regulation of cell growth and differentiation. Our aim was to investigate ZO-1, occludin, and E-cadherin immunohistochemical reactions in tissue microarray blocks containing 57 normal and 62 neoplastic biliary tract samples. We demonstrated that the tight junction components ZO-1, occludin, and E-cadherin are downregulated in carcinomas arising from various compartments of the biliary tract (normal intrahepatic and extrahepatic bile ducts, gallbladder) as compared with their normal sites of origin. These results were confirmed by discriminant analysis yielding clear separation of the three normal sample groups from carcinomas in the corresponding locations.

Indexed as

AgedBile Duct NeoplasmsBile Ducts, IntrahepaticBiomarkers, TumorCadherinsCholangiocarcinomaFemaleHumansImmunohistochemistryMaleMembrane ProteinsOccludinPhosphoproteinsTissue Array AnalysisZonula Occludens-1 ProteinBiomarkers, TumorCadherinsMembrane ProteinsOccludinOCLN protein, humanPhosphoproteinsTJP1 protein, humanZonula Occludens-1 Protein

Identifiers

PMID19184677
OpenAlexW2032330270

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.